Liquidia Corporation is a biopharmaceutical company deeply passionate and committed to the discovery, engineering, and development required to bring novel therapies to patients who need them most, and to the healthcare providers who care for them.
We will continue to combine our proprietary, innovative PRINT® Technology to offer the potential for both better precision and improved clinical outcomes.
To learn more, please visit www.liquidia.com.